期刊文献+

超顺磁性氧化铁增强MRI诊断肝脏局灶性结节增生 被引量:5

SPIO Enhanced MRI Diagnosis of Hepatic Focal Nodular Hyperplasia
暂未订购
导出
摘要 目的 评价超顺磁性氧化铁 (SPIO)对肝脏局灶性结节增生 (FNH)的诊断价值。资料与方法 回顾性分析 7例 7个肝脏FNH的平扫、动态增强及SPIO增强MRI资料。结果 病灶在T1 WI上呈相对低至等信号 ,T2 WI上呈等至相对高信号 ,6个病灶可见中心瘢痕。动态增强扫描 6个病灶以快进慢出方式强化。SPIO增强扫描 6个病灶实质部分信号明显降低 ,5个中心瘢痕显示更清晰。结论 SPIO增强扫描进一步从组织成分方面为FNH诊断提供依据。 Objective To evaluate superparamagnetic iron oxide (SPIO) enhanced MRI in the diagnosis of hepatic focal nodular hyperplasia (FNH).Materials and Methods Plain, dynamic enhanced and SPIO enhanced MRI findings in 7 patients with FNH were retrospectively analyzed.Results The lesions appeared as hypo or iso intensity on T 1WI, and iso or hyper intensity on T 2WI. A central scar was noted in 6 lesions. On dynamic enhanced scans, fast in and slow-out enhancement pattern was seen in 6 lesions. On SPIO enhanced scans, parenchymal signal was markedly decreased in 6 lesions, and the central scar became more clear in 5 lesions.Conclusion Conclusion SPIO enhanced MRI can provide evidence regarding tissue composition which is helpful for the diagnosis of FNH.
出处 《临床放射学杂志》 CSCD 北大核心 2002年第6期432-435,共4页 Journal of Clinical Radiology
关键词 超顺磁性氧化铁增强 肝脏局灶性结节增生 肝肿瘤 磁共振成像 诊断 Contrast media Focal nodular hyperplasia, hepatic MRI
  • 相关文献

参考文献2

二级参考文献12

  • 1[1]Reimer P, Rummeny EJ, Daldrup HE,et al. Clinical results with Resovist: A phase 2 clinical trial. Radiology, 1995, 195:489
  • 2[2]Grangier C, Tourniaire J, Mentha G,et al. Enhancement of liver haemangiomas on T1-weighted MR SE images by superparamagnetic iron oxide particles. JCAT, 1994, 18:888
  • 3[3]Thickman D, Hendrick RE, Jerjian KA,et al. Liver-lesion tissue contrast on MR images: Effect of iron oxide concentration and magnetic field strength. Radiology, 1990, 176:557
  • 4[4]Oudkerk M, Van den Heuvel AG, Wielopolski PA,et al. Hepatic lesions: Detection with ferumoxide-enhanced T1-weighted MR imaging. Radiology, 1997, 203:449
  • 5[5]Chambon C, Clement O, Blanche AL,et al. Superparamagnetic iron oxide as positive MR contrast agents: In vitro and in vivo evidence. Magn Res Imag, 1993, 11:509
  • 6[6]Bach-Gansmo T, Fahlvik A, Ericsson A,et al. Superparamagnetic iron oxide for liver imaging: Comparison among three different preparations. Invest Radiol, 1994, 29:339
  • 7[7]Kopp AF, Laniado M, Dammann F,et al. MR imaging of the liver with Resovist: Safety, efficacy, and pharmacodynamic properties. Radiology, 1997, 204:749
  • 8[8]Fahlvik AK, Holtz E, Klaveness J. Relaxation effect of paramagnetic and superparamagnetic microspheres in liver and spleen. Magn Res Imag, 1990, 8:363
  • 9[9]Seneterre E, Taourel P, Bouvier Y,et al. Detection of hepatic metastases ferumoxides-enhanced imaging versus unenhanced MR imaging and CT during arterial portography. Radiology, 1996, 200:785
  • 10[10] Josephson L, Lewis J, Jacobs P,et al. The effect of iron oxides on proton relaxivity. Magn Res Imag, 1988, 6:647

共引文献45

同被引文献14

引证文献5

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部